Patients often speculate about the causes behind their weird symptoms
Boehringer Ingelheim,Eli Lilly and Company #MedicalAffairs #ClinicalTrials #EvidenceBasedMedicine #Type2Diabetes #CardiovascularOutcomes #SGLT2 #Healthcare #ClinicalResearch #MedicalWriting #PharmaceuticalIndustry#Sanofi To view or add a comment, sign in We are witnessing the end of the "daily pill struggle" for hypertension management
What is the difference between topiramate (Topamax) and phentermine-topiramate (Qsymia)
Under ad libitum fed conditions, the ability to activate -oxidation plays a predominant role in longevity, as evidenced by a 41% reduction in lifespan in nhr-49(nr2041) mutants
Such widespread usage has led to a severe and prolonged international shortage of these drugs 13,14 , with consequent lack of access to treatment for patients with diabetes 15 and the urgent need to issue guidelines for alternative treatments 16
We hypothesized that NDM-1-positive bacteria undergo metabolic compensation under antibiotic pressure, and perturbing NDM-1-induced metabolic homeostasis may reverse their drug resistance